Kratom Reports Surged in First Half of 2026
Poison centers recorded over 3,000 incidents as states moved to regulate the substance.
Updated on Oct. 7, 2026 in Substance Abuse
Live Poll
Should states ban all kratom sales instead of allowing a regulated market for adults?
Poison centers across the United States logged 3,190 kratom-related reports during the first half of 2026. This trend suggests annual report volume will be nearly 68% higher than the 3,434 total cases recorded in 2025.
Why it matters
Concentrated 7-OH compounds found in some products act on the mu-opioid receptor similar to fentanyl and morphine. This increases the risk of dependence and withdrawal, prompting a patchwork of state-level restrictions.
Poison centers documented 233 kratom-associated deaths between 2015 and 2025, with 62% of fatal cases involving concurrent opioid use. Current legislative efforts include 31 states with varying regulations like potency caps.
The players
Drug Enforcement Administration
This federal agency is responsible for enforcing controlled substances laws and recently moved to schedule specific synthetic compounds.
Tennessee
This state enacted a total ban on the sale and possession of kratom in July 2026.
Massachusetts
This state issued an emergency public health order in August 2026 to classify kratom as a Schedule I substance.
The details
States are taking diverse approaches to manage kratom, ranging from total bans in Tennessee to emergency Schedule I classifications in Massachusetts. Meanwhile, manufacturers continue to develop highly concentrated 7-OH products that exceed the natural alkaloid levels typically found in the raw plant.
Timeline
233 kratom-associated deaths were recorded between 2015 and 2025.
Poison centers logged 3,190 kratom-related reports in the first half of 2026.
A state-wide ban on kratom took effect in Tennessee in July 2026.
Massachusetts issued an emergency order restricting kratom in August 2026.
The DEA placed specific synthetic compounds in Schedule I on August 26, 2026.
The Big Picture
The federal effort to classify specific synthetic compounds follows the DEA's Controlled Substances Act scheduling process. This intervention mirrors past regulatory responses to novel substances that demonstrate opioid-like physiological effects.
Consumers may face limited availability of kratom products as states implement age restrictions, potency caps, or total bans. Individuals should be aware that highly concentrated synthetic products carry significant risks of dependence and adverse interactions with other substances.
The takeaway
Kratom products vary significantly in potency, and the rise in synthetic 7-OH concentrations has shifted the safety profile of the substance. Users should exercise extreme caution given the documented links between kratom use and fatal outcomes involving opioids.
Further reading
Find more updates on ongoing regulatory shifts in our Substance Abuse section.
Source note: This article includes information reported by Medical Daily.
Live Poll
Should states ban all kratom sales instead of allowing a regulated market for adults?
